Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
544.00    18.00 (3.42%)
Bid:
540.00
Ask:
543.00
Spread: 3.00 (0.556%)
Market Cap: £534.23m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Contract

24 Mar 2023 07:00

RNS Number : 0820U
Galliford Try Holdings PLC
24 March 2023
 

24 March 2023

Galliford Try Holdings plc

Transaction in Own Shares

Galliford Try Holdings plc ("Galliford Try", or the "Company") announces that on 23 March 2023 it purchased the following number of its ordinary shares of 50 pence each from Peel Hunt LLP as part of the buyback programme announced on 21 September 2022.

Date of purchase:

23/03/2023

Aggregate number of Ordinary Shares purchased:

70,275

Lowest price paid per share (GBp):

172.00

Highest price paid per share (GBp):

172.00

Volume weighted average price paid per share (GBp):

172.0000

Broker

Peel Hunt LLP

 

Galliford Try intends to cancel the purchased shares.

Following settlement of the above purchases, Galliford Try has purchased a total of 3,244,898

shares since the commencement of the buyback programme and will have 107,810,212

 ordinary shares of 50 pence each in issue. There are no shares held in treasury. This figure 107,810,212 represents the total number of voting rights in Galliford Try and can be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Trading Venue / SI

Volume-weighted average price paid per share (Gbp)

Aggregated number of shares purchased

AIMX (AIMX)

-

-

AQUIS (AQXE)

-

-

BATS (BATP)

-

-

BATS (BATE)

-

-

BATS (CHID)

-

-

Chi-X (CHIX)

-

-

Turquoise (TRQX)

-

-

London Stock Exchange (XLON)

172.0000

70,275

Total

172.0000

70,275

 

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as such Regulation has become part of domestic law by virtue of and for the purposes of the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020) and as such Regulation has been amended in such form by any regulations made under that Act), the schedule below contains detailed and aggregated information of the individual trades made by Peel Hunt LLP as part of the buyback programme.

This announcement is made in accordance with the requirements of Listing Rule 12.4.6.

For further enquiries, please contact:

Kevin Corbett, General Counsel & Company Secretary 01895 855 001

Schedule of Purchases - Individual Transactions

Number of shares purchased

Transaction price (pence per share)

Market / Systematic Internaliser

Time of transaction

Trade ID

40000

172

XLON

20230323 14:46:05.288969 +0000

00146657787TRLO0

20000

172

XLON

20230323 16:21:47.079120 +0000

00146669374TRLO0

10275

172

XLON

20230323 16:36:20.266268 +0000

00146672388TRLO0

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTMZGZFLFLGFZM
Date   Source Headline
20th Oct 20227:00 amRNSTransaction in Own Shares
12th Oct 20227:00 amRNSTransaction in Own Shares
11th Oct 20227:00 amRNSTransaction in Own Shares
10th Oct 20224:00 pmRNSAnnual Financial Report
7th Oct 20224:00 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSTransaction in Own Shares
4th Oct 20227:00 amRNSTotal Voting Rights
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20225:30 pmRNSDirector/PDMR Shareholding
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20225:03 pmRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20224:45 pmRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20223:00 pmRNSEmployee Share Trust Trading Plan
22nd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20227:01 amRNSLaunch of Share Buyback Programme
21st Sep 20227:00 amRNSFinal Results
1st Aug 20227:00 amRNSContract
14th Jul 20227:00 amRNSTrading Statement
11th Jul 20227:00 amRNSAcquisition of MCS Control Systems
1st Jul 202211:00 amRNSDirector Declaration
23rd Jun 20227:00 amRNSContract
31st May 20227:00 amRNSTotal Voting Rights
30th May 202210:00 amRNSExercise of share options
10th May 20227:00 amRNSBusiness Briefing
26th Apr 20227:00 amRNSAppointment of Director
1st Apr 20229:10 amRNSConfirmation of Directorate Change
15th Mar 20227:00 amRNSDirectorate Change
4th Mar 20225:03 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSHalf-year Results
9th Feb 20227:00 amRNSContract
19th Jan 20227:00 amRNSTrading Update
31st Dec 202112:36 pmRNSPrice Monitoring Extension
23rd Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 202111:51 amRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSContract
12th Nov 20214:01 pmRNSResult of AGM
12th Nov 20217:00 amRNSAGM Statement
7th Oct 20213:23 pmRNSAcquisition
7th Oct 202110:27 amRNSDirector Declaration
6th Oct 20217:00 amRNSContract
5th Oct 20214:47 pmRNSAnnual Financial Report
23rd Sep 20214:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20214:00 pmRNSDirector/PDMR Shareholding
17th Sep 20211:00 pmRNSEmployee Share Trust Trading Plan
16th Sep 20217:00 amRNSFinal Results
26th Aug 20213:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.